IGF1R and cancer: Typical dysregulated pathways in cancer include IGF-1R, PI3K/AKT1/mammalian target of rapamycin (mTOR), mitogen-activated protein kinase (MAPK)/ERK, glycogen synthase kinase-3β (GSK-3β), or Wnt/β-catenin signaling.